Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,048 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

NCT01482156

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +20 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Washington University School of Medicine Washington University (16) St Louis, Missouri, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • Novartis Investigative Site Wilrijk, Belgium
View Trial Details
Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

NCT02988440

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Hong Kong
View Trial Details
Completed

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

NCT02077933

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Memorial Sloan Kettering Cancer Center SC - BYL719Z2102 New York, United States
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Bordeaux, France
View all 22 locations
View Trial Details
Completed

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

NCT00551070

Conditions
Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
View all 49 locations
View Trial Details

Related conditions